Last reviewed · How we verify
MH004 Ointment
MH004 is a topical ointment formulation designed to treat dermatological conditions through localized therapeutic action.
At a glance
| Generic name | MH004 Ointment |
|---|---|
| Sponsor | Minghui Pharmaceutical (Hangzhou) Ltd |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
Without publicly available detailed mechanism information, MH004 appears to be a topical pharmaceutical formulation in Phase 3 development by Minghui Pharmaceutical. The specific molecular target and mechanism of action are not clearly disclosed in accessible literature, though the ointment format suggests local skin delivery for a dermatological indication.
Approved indications
Common side effects
Key clinical trials
- A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis (PHASE3)
- MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis (PHASE1, PHASE2)
- Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |